Conclusion of non-exclusive pharmaceutical discount agreements for allergen extract

Summary

The tender concerns the conclusion of non-exclusive pharmaceutical discount agreements under Section 130a(8) of the German Social Code Book V for medicines containing allergen extracts from meadow timothy, sweet vernal grass, orchard grass, perennial ryegrass and smooth meadow-grass pollen (ATC V01AA02). DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible. The agreements are intended to run from 1 October 2026 to 30 September 2028, but will end automatically if an exclusive agreement enters into force earlier. The notice does not specify the bidder qualification or compliance requirements; these must be checked in the tender documents.